Armed with positive data from a phase 2b trial, Teva and Sanofi have decided to push their anti-TL1A antibody duvakitug into a phase 3 programme in inflammatory bowel disease (IBD). The results of the ...

We've tested hundreds of smart home products in more than 20 categories to help determine which ones are best for every room in (and out of) the house. I'm PCMag's managing editor for consumer ...